Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Most Cited Paper
in Alzheimer's disease research and treatments
18 Months Post-Publication
Class of 2026
“Biomarker-based staging of Alzheimer disease: rationale and clinical applications”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
Biomarker-based staging · Alzheimer's disease · Amyloid PET · Tau PET · Cerebrospinal fluid biomarkers · Blood-based biomarkers · Aβ42/40 ratio · Phosphorylated tau · Preclinical Alzheimer's disease · ATN classification framework · Disease staging · Clinical diagnostic criteria · Neurodegeneration biomarkers · Cognitive impairment continuum · Biomarker cutpoints · Disease progression · clinical trial eligibility criteria · Disease-modifying therapies · Early detection · Blood-based diagnostics
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Alzheimer's disease research and treatments Papers, Class of 2026. https://pri.pepkio.com/top-papers/alzheimer-s-disease-research-and-treatments/2026. Accessed 2026-07-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459